About Parmax Pharma
Parmax Pharma is a company based in Rajkot (India) founded in 1994. The company has 9 employees as of April 08, 2024. Parmax Pharma offers products and services including Active Pharmaceutical Ingredients, Contract Manufacturing Operations, and Bulk Drugs. Parmax Pharma operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Rajkot, India
- Employees 9 as on 08 Apr, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Parmax Pharma Ltd.
-
Annual Revenue
$1.3 M (USD)-28.21as on Mar 31, 2024
-
Net Profit
-$671.79 K (USD)-5425.72as on Mar 31, 2024
-
EBITDA
-$393.77 K (USD)-249.54as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
9
as on Apr 08, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Parmax Pharma
Parmax Pharma is a publicly listed company on the BSE with ticker symbol PARMAX in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Parmax Pharma
Parmax Pharma offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients, Contract Manufacturing Operations, and Bulk Drugs.
Production of complex molecules for pharmaceutical formulations using advanced techniques.
Custom manufacturing services for pharmaceutical companies' needs and requirements.
Creation of essential drugs like Ampicilin for industry use.
Funding Insights of Parmax Pharma
Detailed funding history for Parmax Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Parmax Pharma
Investment portfolio details for Parmax Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Parmax Pharma
Detailed financials for Parmax Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Parmax Pharma Comparisons
Peer comparison for Parmax Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Parmax Pharma
Parmax Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Parmax Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Parmax Pharma
Complete news archive for Parmax Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Parmax Pharma
Parmax Pharma was founded in 1994.
Parmax Pharma is headquartered in Rajkot, India. It is registered at Rajkot, Gujarat, India.
As of Apr 08, 2024, the latest employee count at Parmax Pharma is 9.
Annual revenue of Parmax Pharma is $1.3M as on Mar 31, 2024.
Parmax Pharma Ltd was established in 1994 and is based in Rajkot, India. Operations are centered in the pharmaceutical sector, where bulk drugs, drug intermediates, and specialty chemicals are manufactured and sold. Scientific expertise is applied alongside manufacturing capabilities to support activities in the pharmaceutical segment and related industries.
Parmax Pharma's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Parmax Pharma offers Active Pharmaceutical Ingredients, Contract Manufacturing Operations, and Bulk Drugs.
Yes, Parmax Pharma is publicly traded on BSE under the ticker symbol PARMAX.
The ticker symbol of Parmax Pharma is PARMAX on BSE.